Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tenon Medical (TNON) EBIT (2021 - 2025)

Historic EBIT for Tenon Medical (TNON) over the last 5 years, with Q3 2025 value amounting to -$3.4 million.

  • Tenon Medical's EBIT fell 550.54% to -$3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.1 million, marking a year-over-year increase of 462.36%. This contributed to the annual value of -$13.8 million for FY2024, which is 1246.9% up from last year.
  • Latest data reveals that Tenon Medical reported EBIT of -$3.4 million as of Q3 2025, which was down 550.54% from -$2.9 million recorded in Q2 2025.
  • Over the past 5 years, Tenon Medical's EBIT peaked at -$189000.0 during Q1 2021, and registered a low of -$7.9 million during Q4 2022.
  • In the last 5 years, Tenon Medical's EBIT had a median value of -$3.3 million in 2022 and averaged -$3.4 million.
  • Per our database at Business Quant, Tenon Medical's EBIT plummeted by 100000.0% in 2022 and then soared by 6038.09% in 2023.
  • Quarter analysis of 5 years shows Tenon Medical's EBIT stood at -$2.6 million in 2021, then tumbled by 209.45% to -$7.9 million in 2022, then soared by 60.38% to -$3.1 million in 2023, then fell by 1.02% to -$3.2 million in 2024, then fell by 6.9% to -$3.4 million in 2025.
  • Its EBIT stands at -$3.4 million for Q3 2025, versus -$2.9 million for Q2 2025 and -$3.7 million for Q1 2025.